Aaron Jenkins, PhD

Director, Value and Evidence
Pfizer R&D UK Ltd
Tadworth, Surrey, England, United Kingdom

Disclosure information not submitted.

Presentation(s):

• Reduction in barbiturate prescription fills and quantity dispensed following initiation of rimegepant treatment: A real-world administrative claims study

  POSTER ABSTRACT